Clinical Trials Logo

Stage IIA Prostate Cancer clinical trials

View clinical trials related to Stage IIA Prostate Cancer.

Filter by:

NCT ID: NCT03880422 Recruiting - Obesity Clinical Trials

Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors

Start date: May 2, 2019
Phase: N/A
Study type: Interventional

This trial studies how well nutrition and exercise interventions work in reducing androgen deprivation therapy-induced obese frailty in prostate cancer survivors. Individualized nutrition and exercise advice for prostate cancer patients on androgen deprivation therapy may help to reduce obese frailty and change the levels of myokines in blood.

NCT ID: NCT03233555 Completed - Clinical trials for Stage II Breast Cancer

Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal Cancer

Start date: September 3, 2013
Phase: N/A
Study type: Interventional

This study tests four different methods of educating patients about follow-up care (NCI facing forward, brochure, EXCELS website alone, EXCELS health coaching alone and EXCELS website & health coaching combination) after cancer treatment ends. While it is known that patients need information to guide follow-up it remains unknown how to best provide this in primary care.

NCT ID: NCT03122743 Completed - Clinical trials for Recurrent Prostate Carcinoma

Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer

Start date: February 22, 2017
Phase:
Study type: Observational

This pilot research trial studies the collection of serum samples in studying emotional stress in patients with prostate cancer. Studying serum samples from patients with prostate cancer in the laboratory may help doctors determine if levels of epinephrine and cortisol, substances the body makes when stressed, rise or fall with how patients are feeling and/or if those levels are related to clinical information related to prostate cancer.

NCT ID: NCT03103321 Completed - Clinical trials for Stage III Prostate Cancer

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

Start date: July 14, 2017
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies how well decision aids work in improving knowledge in patients with newly diagnosed prostate cancer. Decision aids may improve patients' knowledge of their condition and options for treatment, and may also help when talking with their doctor.

NCT ID: NCT02767921 Terminated - Clinical trials for Stage III Prostate Cancer

sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer

Start date: August 2, 2016
Phase: Phase 1
Study type: Interventional

This pilot clinical trial studies the side effects of recombinant EphB4-HSA fusion protein before surgery in treating patients with transitional cell carcinoma of the bladder, prostate cancer, or kidney cancer. Recombinant EphB4-HSA fusion protein may block an enzyme needed for tumor cells to multiply and may also prevent the growth of new blood vessels that bring nutrients to the tumor. Giving recombinant EphB4-HSA fusion protein before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.

NCT ID: NCT02420652 Terminated - Clinical trials for Recurrent Prostate Carcinoma

Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

PRIMA
Start date: June 23, 2015
Phase: Phase 2
Study type: Interventional

This randomized phase II trial studies how well metformin hydrochloride and aspirin work in treating patients with hormone-dependent prostate cancer that has progressed after surgery or radiation therapy. Metformin hydrochloride and aspirin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether giving metformin hydrochloride and aspirin together can slow the growth of prostate cancer.

NCT ID: NCT02346253 Active, not recruiting - Clinical trials for Prostate Adenocarcinoma

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Start date: January 13, 2015
Phase: N/A
Study type: Interventional

This trial studies the side effects and how well high-dose brachytherapy works in treating patients with prostate cancer that has not spread to other parts of the body. Brachytherapy is a type of radiation therapy in which radioactive material sealed in needles, seeds, wires, or catheters is placed directly into or near a tumor and may be a better treatment in patients with prostate cancer.

NCT ID: NCT02250014 Completed - Clinical trials for Recurrent Prostate Cancer

The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer

Start date: October 5, 2015
Phase: Phase 1
Study type: Interventional

This randomized pilot phase I trial studies how well sargramostim after cryotherapy works in treating patients with prostate cancer. Biological therapies, such as sargramostim, use substances made from living organisms that may stimulate the immune system in different ways and stop tumor cells from growing. Cryosurgery, also known as cryotherapy, kills tumor cells by freezing them. Giving sargramostim after cryotherapy may work better in treating prostate cancer.

NCT ID: NCT02237612 Completed - Clinical trials for Adenocarcinoma of the Prostate

Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer

Start date: January 2009
Phase: N/A
Study type: Interventional

This pilot clinical trial studies how well diffusion-weighted magnetic resonance imaging (MRI) works in staging patients with prostate cancer that has not spread to nearby lymph nodes or other parts of the body. New imaging techniques, such as diffusion-weighted MRI, may be a less invasive way of predicting the stage and grade of prostate cancer.

NCT ID: NCT02217709 Completed - Clinical trials for Adenocarcinoma of the Prostate

Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer

Start date: September 8, 2014
Phase: Phase 2
Study type: Interventional

This phase II trial studies phenelzine sulfate in treating patients with prostate cancer that has not spread to other parts of the body and has come back. Phenelzine sulfate is a type of antidepressant that works by decreasing the amount of a protein called monoamine oxidase (MAO). MAO drugs may have an anticancer effect in prostate cancer.